Literature DB >> 30536760

Neutropenia in the age of genetic testing: Advances and challenges.

Elissa Furutani1, Peter E Newburger1,2, Akiko Shimamura1.   

Abstract

Identification of genetic causes of neutropenia informs precision medicine approaches to medical management and treatment. Accurate diagnosis of genetic neutropenia disorders informs treatment options, enables risk stratification, cancer surveillance, and attention to associated medical complications. The rapidly expanding genetic testing options for the evaluation of neutropenia have led to exciting advances but also new challenges. This review provides a practical guide to germline genetic testing for neutropenia.
© 2018 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30536760      PMCID: PMC6380907          DOI: 10.1002/ajh.25374

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Genetic predisposition to MDS: diagnosis and management.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 2.  Benign ethnic neutropenia.

Authors:  Suheil Albert Atallah-Yunes; Audrey Ready; Peter E Newburger
Journal:  Blood Rev       Date:  2019-06-21       Impact factor: 8.250

3.  Diagnosis and therapeutic decision-making for the neutropenic patient.

Authors:  James A Connelly; Kelly Walkovich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Impaired myelopoiesis in congenital neutropenia: insights into clonal and malignant hematopoiesis.

Authors:  Julia T Warren; Daniel C Link
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Identification of GFI1 mutations in adult patients with congenital neutropenia.

Authors:  Erasmia Boutakoglou; Maksim Klimiankou; Grigorios Tsaknakis; Elias Drakos; Julia Skokowa; Helen A Papadaki
Journal:  Ann Hematol       Date:  2022-09-16       Impact factor: 4.030

6.  Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor.

Authors:  David C Dale; Audrey Anna Bolyard; James A Shannon; James A Connelly; Daniel C Link; Mary Ann Bonilla; Peter E Newburger
Journal:  Blood Adv       Date:  2022-07-12

Review 7.  Gene Therapy to the Retina and the Cochlea.

Authors:  Ryan Crane; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Front Neurosci       Date:  2021-03-17       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.